{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:45:51Z","timestamp":1788929151483,"version":"build-2803163510"},"reference-count":15,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej13-0353","type":"journal-article","created":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T02:05:37Z","timestamp":1380333937000},"page":"35-40","source":"Crossref","is-referenced-by-count":45,"title":["Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study"],"prefix":"10.1507","volume":"61","author":[{"given":"Yoshihiro","family":"Miyake","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Hypertension, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Hypertension, Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yuhu 879-5593, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ueshiba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toho University School of Medicine, Tokyo 143-0015, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama 241-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Health Care Center, Kochi University, Kochi 780-8520, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Allergy, Institute of Medical Science, The University of Tokyo, Tokyo 108-8039, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asahikawa Medical University, Asahikawa 078-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asahikawa Medical University, Asahikawa 078-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Katsumata","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hokkaido University School of Medicine, Sapporo 060-8635, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yanase","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Conn JW (1955) Presidential address. Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome. <i>J Lab Clin Med<\/i> 45: 3-17."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, et al. (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. <i>J Clin Endocrinol Metab<\/i> 93: 3266-3281.","DOI":"10.1210\/jc.2008-0104"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. <i>J Am Coll Cardiol<\/i> 45: 1243-1248.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism: the Japan Endocrine Society 2009. <i>Endocr J<\/i> 58: 711-721.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nishikawa T, Omura M, Saito J, Matsuzawa Y (2012) Primary aldosteronism: comparison between guidelines of the Japanese and the US Endocrine Society. <i>Expert Rev Endocrinol Metab<\/i> 7: 637-645.","DOI":"10.1586\/eem.12.65"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective Study on the Prevalence of Secondary Hypertension among Hypertensive Patients Visiting a General Outpatient Clinic in Japan. <i>Hypertens Res <\/i>27: 193-202.","DOI":"10.1291\/hypres.27.193"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Porteri E, et al. (2006) prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. <i>J Am Coll Cardiol<\/i> 48: 2293-2300.","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA (1993) Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. <i>Clin Exp Pharmacol Physiol<\/i> 20: 296-298.","DOI":"10.1111\/j.1440-1681.1993.tb01687.x"},{"key":"9","unstructured":"9. Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, et al. (2012) The nationwide epidemiological study of primary aldosteronism, adrenal subclinical Cushing&rsquo;s syndrome, Addison&rsquo;s disease (second survey, final report). The annual report of the Ministry of Health and Welfare &ldquo;Disorder of Adrenal Hormones&rdquo; Research Committee, Japan2012 pp23-38."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nishikawa T, Saito J, Omura M (2007) Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? <i>Endocr J<\/i> 54: 487-495.","DOI":"10.1507\/endocrj.KR-105"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Armanini D, Scaroni C, Mattarello MJ, Fiore C, Albiger N, et al. (2005) Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate. <i>J Endocrinol Invest<\/i> 28: 236-240.","DOI":"10.1007\/BF03345379"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Armanini D, Fiore C, Pellati D (2007) Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate. <i>Hypertension<\/i> 50: e69-e70.","DOI":"10.1161\/HYPERTENSIONAHA.107.096925"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lucatello B, Benso A, Tabaro I, Capello E, Caprino MP, et al. (2013) Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion. <i>Eur J Endocrinol <\/i>168: 525-532.","DOI":"10.1530\/EJE-12-0912"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yoneda T, Demura M, Takata H, Kometani M, Karashima S, et al. (2012) Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. <i>J Clin Endocrinol Metab <\/i>97: 1109-1113.","DOI":"10.1210\/jc.2011-2563"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, et al. (2008) Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. <i>Expert Opin Pharmacother<\/i> 9: 509-515.","DOI":"10.1517\/14656566.9.4.509"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/1\/61_EJ13-0353\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:39:55Z","timestamp":1618295995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/1\/61_EJ13-0353\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej13-0353","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}